<div id="modal-study_design" data-reveal class="reveal-modal medium" aria-labelledby="modal-study_design-title" aria-hidden="true" role="dialog">
  <h3 id="modal-study_design-title">Study Details<sup>2</sup></h3>
  <ul>
    <li>Phase 1 study in healthy volunteers (N=9)</li>
    <li>Dose: 30&nbsp;&mu;g/kg IV bolus + 4 &mu;g/kg/min IV infusion</li>
    <li>KENGREAL<sup>&reg;</sup> (cangrelor) blood levels and platelet activity were assessed over 150 minutes by whole blood impedance aggregometry in response to 20&nbsp;&mu;M of adenosine diphosphate (ADP)</li>
  </ul>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-champion_study_design" data-reveal class="reveal-modal small" aria-labelledby="modal-champion_study_design-title" aria-hidden="true" role="dialog">
  <h3 id="modal-champion_study_design-title">CHAMPION PHOENIX study design<sup>4</sup></h3>
  <table cellpadding="0" cellspacing="0" border="0">
    <caption>
      <p class="disclaimers indent">ACS=acute coronary syndromes; NSTE-ACS=non&ndash;ST-segment elevation ACS; SA=stable angina; STEMI=ST-segment elevation myocardial infarction.</p>
    </caption>
    <tbody>
      <tr>
        <td>Study Type</td>
        <td>Randomized, double-blind, double-dummy, phase 3 trial</td>
      </tr>
      <tr>
        <td>Purpose</td>
        <td>Compare periprocedural thrombotic events with KENGREAL<sup>&reg;</sup> (cangrelor) versus clopidogrel (300 or 600&nbsp;mg, per standard of care) in patients needing&nbsp;PCI</td>
      </tr>
      <tr>
        <td>Patient Population</td>
        <td>
          <ul>
            <li>N=11,145 (randomized patients)</li>
            <li>N=10,942 (modified intention-to-treat)</li>
            <li>All-comer patients requiring PCI who were P2Y<sub>12</sub> inhibitor na&iuml;ve</li>
            <li>Similar patient population as that seen in PCI practice (stable angina, NSTE&#8209;ACS,&nbsp;STEMI)<sup>5,6</sup></li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Key Inclusion Criteria</td>
        <td>
          <ul>
            <li>SA/NSTE-ACS: Confirmed need for PCI (by angiography)</li>
            <li>STEMI: Intent for emergent PCI</li>
          </ul>
        </td>
      </tr>
      <tr>
        <td>Key Exclusion Criteria</td>
        <td>
          <ul>
            <li>Treated with an oral P2Y<sub>12</sub> inhibitor in the past 7&nbsp;days</li>
            <li>Planned GP IIb/IIIa inhibitor use</li>
          </ul>
        </td>
      </tr>
    </tbody>
  </table>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-breakdown" data-reveal class="reveal-modal full" aria-labelledby="modal-breakdown-title" aria-hidden="true" role="dialog">
  <h3 id="modal-breakdown-title">Breakdown by individual endpoints: <br>Outcomes at 48 hours, mITT<sup>*1,4</sup></h3>
  <table cellpadding="0" cellspacing="0" border="0">
    <caption>
      <p class="disclaimers indent">mITT=modified intention-to-treat.<br>Note: If a subject had more than one event at 48&nbsp;hours, then worst outcome counted (death&gt;MI&gt;IDR&gt;ST).</p>
      <p class="disclaimers indent"><sup class="undent">*</sup>The mITT population is all randomized subjects who received at least one dose of study drug and underwent the index PCI procedure.</p>
      <p class="disclaimers indent"><sup class="undent">&dagger;</sup>Based on logistic model adjusted for loading dose and baseline patient status for primary endpoint.</p>
    </caption>
    <thead>
      <tr>
        <th valign="top" width="30%"></th>
        <th valign="top" width="19%" class="highlight">KENGREAL<sup>&reg;</sup> <span class="block normal">(cangrelor) <span class="block normal">(n=5472)</span></th>
        <th valign="top" width="19%">Clopidogrel <span class="block normal">(n=5470)</span></th>
        <th valign="top" width="20%">OR <span class="block normal">(95%CI)</span></th>
        <th valign="top"><i>P</i> value</th>
      </tr>
      <tr>
        <th class="strong">Primary outcome, adjusted</td>
        <th class="highlight"></td>
        <th colspan="3"></td>
      </tr>
    </thead>
    <tfoot>
      <tr>
        <td>Stent thrombosis (secondary&nbsp;endpoint)</td>
        <td class="semibold highlight text-center">27/5470 (0.5%)</td>
        <td class="semibold text-center">36/5469 (0.7%)</td>
        <td colspan="2"></td>
      </tr>
    </tfoot>
    <tbody>
      <tr>
        <td class="semibold">Death/MI/IDR/ST</td>
        <td class="semibold highlight text-center">257/5470 (4.7%)</td>
        <td class="semibold text-center">322/5469 (5.9%)</td>
        <td class="semibold text-center">0.78 (0.66, 0.93)<sup>&dagger;</sup></td>
        <td class="semibold text-center">0.005</td>
      </tr>
      <tr>
        <td class="strong">Secondary efficacy outcomes at&nbsp;48 hours, mITT</td>
        <td class="semibold highlight text-center"></td>
        <td colspan="3"></td>
      </tr>
      <tr>
        <td>Death</td>
        <td class="semibold highlight text-center">18/5470 (0.3%)</td>
        <td class="semibold text-center">18/5469 (0.3%)</td>
        <td colspan="2"></td>
      </tr>
      <tr>
        <td>MI</td>
        <td class="semibold highlight text-center">202/5470 (3.7%)</td>
        <td class="semibold text-center">254/5469 (4.6%)</td>
        <td colspan="2"></td>
      </tr>
      <tr>
        <td>IDR</td>
        <td class="semibold highlight text-center">10/5470 (0.2%)</td>
        <td class="semibold text-center">14/5469 (0.3%)</td>
        <td colspan="2"></td>
      </tr>
    </tbody>
  </table>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-subgroups_bleeding" data-reveal class="reveal-modal full" aria-labelledby="modal-subgroups_bleeding-title" aria-hidden="true" role="dialog">
  <h3 id="modal-subgroups_bleeding-title">Any bleeding at 48 hours (non&ndash;CABG-related)<sup>*1,4</sup></h3>
  <figure>
    <img alt="" src="../shared/img/chart-subgroups_bleeding.svg">
    <figcaption class="row">
      <div class="columns column-12">
        <ul class="disclaimers">
          <li><span class="undent">*</span>Safety population is all randomized subjects who received at least one dose of study drug.</li>
        </ul>
      </div>
    </figcaption>
  </figure>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-supplementary_endpoint" data-reveal class="reveal-modal full" aria-labelledby="modal-supplementary_endpoint-title" aria-hidden="true" role="dialog">
  <h3 id="modal-supplementary_endpoint-title">Supplementary FDA-requested endpoint: Outcomes at 48 hours, mITT<sup>1</sup></h3>
  <p>This analysis omitted 2 subcomponent events from the primary endpoint of lesser clinical significance:</p>
  <aside class="row">
    <div class="columns column-5">
      <ul>
        <li>Intraprocedural stent thrombosis</li>
      </ul>
    </div>
    <div class="columns column-7">
      <ul>
        <li>MI with &lt;10-fold increase in CK-MB, or with &lt;5-fold increase in CK-MB in the presence of new Q waves or new left bundle branch block (LBBB)</li>
      </ul>
    </div>
  </aside>
  <div class="row">
    <table cellpadding="0" cellspacing="0" border="0">
      <caption class="row">
        <div class="columns column-5">
          <p class="disclaimers indent">ARC=Academic Research Consortium; CK&#8209;MB=creatine kinase MB isoenzyme; MI=myocardial infarction; SCAI=Society for Cardiovascular Angiography and Interventions; ST=stent&nbsp;thrombosis.</p>
        </div>
        <div class="columns column-7">
          <p class="disclaimers indent">Note: If a subject had more than one event at 48&nbsp;hours, then worst outcome counted (death&gt;SCAI MI&gt;IDR&gt;ARC-ST).</p>
          <p class="disclaimers indent"><sup class="undent">*</sup>SCAI MI: CK-MB &ge;10X ULN, or CK-MB &ge;5X ULN with new Q waves or new&nbsp;LBBB.</p>
          <p class="disclaimers indent"><sup class="undent">&dagger;</sup>ARC-ST defined according to the ARC definition.</p>
        </div>
      </caption>
      <thead>
        <tr>
          <th width="25%"></th>
          <th width="20%" class="highlight">KENGREAL<sup>&reg;</sup> (cangrelor) <span class="block normal">(n=5470)</span></th>
          <th width="20%" class="text-center">Clopidogrel <span class="block normal">(n=5469)</span></th>
          <th class="text-center">KENGREAL vs clopidogrel OR <span class="normal">(95% CI)</span></th>
        </tr>
      </thead>
      <tfoot>
        <tr>
          <td></td>
          <td class="highlight"></td>
          <td></td>
        </tr>
      </tfoot>
      <tbody>
        <tr>
          <td class="strong">Supplementary endpoint Death/SCAI MI/<br>IDR/ARC-ST</td>
          <td class="semibold highlight text-center">79 (1.4%)</td>
          <td class="semibold text-center">114 (2.1%)</td>
          <td class="semibold text-center">0.69 (0.52, 0.92)</td>
        </tr>
        <tr>
          <td class="semibold">Death</td>
          <td class="semibold highlight text-center">18 (0.3%)</td>
          <td class="semibold text-center">18 (0.3%)</td>
          <td class="empty"></td>
        </tr>
        <tr>
          <td class="semibold">SCAI MI*</td>
          <td class="semibold highlight text-center">48 (0.9%)</td>
          <td class="semibold text-center">80 (1.5%)</td>
          <td class="empty"></td>
        </tr>
        <tr>
          <td class="semibold">IDR</td>
          <td class="semibold highlight text-center">13 (0.2%)</td>
          <td class="semibold text-center">16 (0.3%)</td>
          <td class="empty"></td>
        </tr>
        <tr>
          <td class="semibold">ARC-ST<sup>&dagger;</sup></td>
          <td class="semibold highlight text-center">0 (0.0%)</td>
          <td class="semibold text-center">0 (0.0%)</td>
          <td class="empty"></td>
        </tr>
      </tbody>
    </table>
  </div>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-subgroups_endpoint" data-reveal class="reveal-modal full" aria-labelledby="modal-subgroups_endpoint-title" aria-hidden="true" role="dialog">
  <h3 id="modal-subgroups_endpoint-title">Primary composite endpoint by&nbsp;subgroups<sup>1,4</sup></h3>
  <figure class="row">
    <div class="columns column-9">
      <img alt="" src="../shared/img/chart-subgroups_endpoint.svg">
    </div>
    <figcaption class="columns column-3">
      <p>Note: The figure to the left presents effects in various subgroups, most of which are baseline characteristics and most of which were prespecified (patient presentation and weight were not prespecified subgroups). The 95% confidence limits that are shown do not take into account how many comparisons were made, nor do they reflect the effect of a particular factor after adjustment for all other factors. Apparent homogeneity or heterogeneity among groups should not be overinterpreted.</p>
    </figcaption>
  </figure>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-angio-kenneth" data-reveal class="reveal-modal small" aria-labelledby="modal-angio-kenneth-title" aria-hidden="true" role="dialog">
  <figure class="row collapse panel">
    <div class="columns column-8">
      <img alt="" src="../shared/img/angio-kenneth.jpg">
    </div>
    <figcaption class="columns column-4">
      <dl>
        <dt>
          <em class="ke_heart"></em>Cardiac <br>imaging
        </dt>
        <dd>
          <ul class="no-bullet">
            <li>Proximal LAD occlusion at the origin of the first diagonal branch</li>
            <li>LCX with a focal 70% stenosis in a medium-sized OM2</li>
            <li>Dominant RCA with 80% mid-RCA stenosis, 60% PDA&nbsp;stenosis</li>
            <li>LVEF 35% with moderate anterior and apical akinesis</li>
          </ul>
        </dd>
      </dl>
    </figcaption>
  </figure>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>
<div id="modal-angio-rafael" data-reveal class="reveal-modal small" aria-labelledby="modal-angio-rafael-title" aria-hidden="true" role="dialog">
  <figure class="row collapse panel">
    <div class="columns column-8">
      <img alt="" src="../shared/img/angio-rafael.jpg">
    </div>
    <figcaption class="columns column-4">
      <dl>
        <dt>
          <em class="ke_heart"></em>Cardiac <br>imaging
        </dt>
        <dd>
          <ul class="no-bullet">
            <li>70% restenosis of&nbsp;OM1</li>
          </ul>
        </dd>
      </dl>
    </figcaption>
  </figure>
  <a class="close-reveal-modal" aria-label="Close">&#215;</a>
</div>